[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338404-105":59,"doc-detail-338404-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","generation-and-maintenance-of-patient-derived-endometrial-cancer-organoids","Generation and Maintenance of Patient-Derived Endometrial Cancer Organoids","","Endometrial cancer (EC) drives high gynecologic cancer morbidity and mortality in the U.S., with death rates rising notably for high-grade disease. Three-dimensional patient-derived organoid (PDO) models are described as a more faithful alternative to traditional 2D cell lines by preserving patient tumor biological and genetic complexity. A cultivation protocol enables PDO generation from normal endometrium and EC across multiple subtypes. Expanded organoids support long-term passaging, investigation of tumor behavior and drug responses, and improved mechanistic insight to inform more effective, individualized therapeutic strategies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/generation-and-maintenance-of-patient-derived-endometrial-cancer-organoids/338404/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/generation-and-maintenance-of-patient-derived-endometrial-cancer-organoids/338404.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why are 3D patient-derived organoid (PDO) models important for endometrial cancer research?","Question",{"text":113,"@type":114},"They better replicate the biological and genetic complexity of a patient’s tumor than traditional 2D cell lines by preserving key microenvironmental features.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What does the protocol enable researchers to do with organoids?",{"text":118,"@type":114},"It supports cultivation from normal endometrium and endometrial cancers, expansion across passages, and banking to enable studies of tumor behavior and drug responses.",{"name":120,"@type":111,"acceptedAnswer":121},"How does this approach address challenges of current experimental models?",{"text":122,"@type":114},"It overcomes shortcomings of immortalized 2D cell lines and mouse models, which fail to reliably represent the 3D structure and human endometrium biology needed for accurate EC modeling.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},338404,1790462998,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Generation and Maintenance of PatientDerived Endometrial Cancer Organoids  \nMali Barbi1, 2, 4, \\#, Divya Gowthaman1, 2, \\#, Arielle Katcher1, 2, Megan Gorman 1, 2, Brian Yueh1, Aaron Nizam1, 2, Charlie Chung1, Erdogan Oguzhan Akyildiz1, Marina Frimer2, 3, 4, Gary L. Goldberg1, 2, 3, 4 and Semir Beyaz1, *  \n1Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA  \n2Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Long Island Jewish Medical Center, Zucker School of Medicine at Hofstra/Northwell, Northwell Health, New Hyde Park, NY, USA  \n3Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA 4Northwell Health Cancer Institute, New Hyde Park, NY, USA  \n\\#Contributed equally to this work.  \n*For [correspondence:](correspondence: beyaz@cshl.edu)[ ](correspondence: beyaz@cshl.edu)[beyaz@cshl.edu](correspondence: beyaz@cshl.edu)  \nAbstract  \nEndometrial cancer (EC) is the leading cause of gynecologic cancer morbidity and mortality in the U.S. Despite advancements in cancer research, EC death rates are increasing, particularly high-grade endometrial cancers. The development of three-dimensional (3D) patient-derived organoid (PDO) models for EC is crucial, as they provide a more accurate representation of the biological and genetic complexity of a patient’s tumor compared to traditional 2D cell lines. Here, we describe a protocol for cultivating PDO models from normal endometrium and EC across different EC subtypes. These EC PDO models can be expanded across multiple passages and facilitate the exploration of tumor behavior and drug responses, thereby advancing our understanding of the disease and potentially leading to more effective and individualized novel therapeutic strategies.  \nKey features  \n• Establishment of patient-derived EC and normal endometrium organoids.  \n• Accurate replication of the various histologic and molecular subtypes of EC within the organoids.  \n• Our approach provides a clinically relevant platform for studying EC development, metastasis, progression, and recurrence.  \n• It offers potential for developing targeted therapeutic interventions tailored to specific EC subtypes.  \nKeywords: Endometrial cancer, Patient-derived organoids, Long-term expansion, Tumor selectivity, Translational research  \nGraphical overview  \nSchematic overview of endometrial cancer and normal organoid preparation from patient-derived samples  \nBackground  \nEndometrial cancer (EC) is the fourth most common cancer and the sixth leading cause of cancer mortality among women in the US. It is one of the few cancers experiencing a rapid rise in both incidence and mortality rates, and by 2040, it is projected to become the third most prevalent cancer and the fourth leading cause of cancer death, surpassing lung and colorectal cancers. Furthermore, EC presents a significant challenge due to its racial disparity, with the largest Black/White difference in 5-year relative survival among all cancers (63% vs. 84%) [1–4] . These concerning trends highlight the urgent need for research into the molecular and cellular basis of EC to advance our understanding and develop more effective therapeutic strategies.  \nImmortalized 2D cell lines and mouse models have been commonly used for EC research; however, they do not provide reliable models. 2D cell culture systems lack the critical 3D structure inherent in primary endometrial tissue, affecting glandular cell function influenced by their microenvironment and orientation. Similarly, mouse models do not accurately represent the biology of the human endometrium, highlighting the need for reliable biological models that mimic human EC biology [5,6] .  \nPatient-derived organoids (PDOs) are 3D structures that precisely replicate the microenvironment and cellular composition of endometrial tissue, providing a clinically relevant model for studying specific histologic and molecular subtypes of EC [7–11] . This is particularly valuable for the rarer and mo","cbCail58wflftGqg","https://ap.wps.com/l/cbCail58wflftGqg","pdf",2346548,11,"English","# Abstract\n# Key features\n# Background\n## Limitations of existing models\n## Advantages of patient-derived organoids\n# Protocol overview\n# Materials and reagents","[{\"question\":\"Why are 3D patient-derived organoid (PDO) models important for endometrial cancer research?\",\"answer\":\"They better replicate the biological and genetic complexity of a patient’s tumor than traditional 2D cell lines by preserving key microenvironmental features.\"},{\"question\":\"What does the protocol enable researchers to do with organoids?\",\"answer\":\"It supports cultivation from normal endometrium and endometrial cancers, expansion across passages, and banking to enable studies of tumor behavior and drug responses.\"},{\"question\":\"How does this approach address challenges of current experimental models?\",\"answer\":\"It overcomes shortcomings of immortalized 2D cell lines and mouse models, which fail to reliably represent the 3D structure and human endometrium biology needed for accurate EC modeling.\"}]","Generation and Maintenance of Patient-Derived Endometrial Cancer Organoids | PDF",1790023509,28,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5a5c6c74c6b5c48978fe1b55c9fe0ce5.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd4d7fee9dc4a755a67f4d4561083b46.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cea4ff352cd503cd2fdbf58ffe13768a.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ada3a1d27719565dda94d1e6f952714.webp",980,1385]